A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics, of VX-993
Clinical trial NCT06226454 · COMPLETED
Trial details
- NCT number
- NCT06226454
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-04
- Primary completion
- 2024-06-12
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.